Objective: Myxofibrosarcoma has high frequency of local recurrence after surgery. To determine an optimal treatment for recurrent tumors, clinical features of recurrent cases should be characterized. Methods: We performed a retrospective analysis of 30 patients with recurrent myxofibrosarcoma who underwent surgery between 1999 and 2008. Results: A negative margin after surgery was achieved in only 12 patients (40.0%). The 5-year rerecurrence free-survival rate was 31.7%. The 5-year re-recurrence free survival for those with positive histological margin and those with negative margin were 9.8% and 62.3%, respectively, which indicated that a positive margin was the significant predictor of poor prognosis (P = 0.006). In 21 patients with recurrent myxofibrosarcoma in the extremities, 10 patients (47.6%) ultimately underwent amputation in the follow-up period and the 5-year amputation-free survival rate was 62.5%. The 5-year metastasis-free survival rates and the 5-year overall survival rates were 84.8% and 83.6%, respectively. Conclusions: In this study, the majority of recurrent cases could not achieve negative margins; notably, a positive margin is a significant poor prognostic indicator of local re-recurrence in patients with recurrent myxofibrosarcoma. To control local recurrence of myxofibrosarcoma was extremely difficult and amputation is often needed in the extremity cases.
Introduction
Myxofibrosarcoma (MFS) is a common type of adult soft-tissue sarcoma, particularly affecting the extremities in the elderly (1) . Because of the establishment of the histological diagnosis of MFS after the World Health Organization (WHO) classification in 2002 and 2013 (1, 2) , the number of diagnosed MFS cases has significantly increased in recent years.
Surgery has been the mainstay of treatment of MFS (3, 4) ; clinical effects of radiotherapy and chemotherapy on MFS remain to be proven (5) (6) (7) (8) . Therefore, adequate primary surgical resection with a negative histological margin is the most important factor for improving clinical outcomes of MFS. However, MFS has a potential for unusual infiltrative growth (1, 4, 9) . Especially, a superficial origin of MFS is significantly related to infiltrative growth activity that found as a tail-like pattern on gadolinium-enhanced magnetic resonance imaging (MRI). The tail-like pattern is associated with poorer prognosis (10) .
Previous reports have documented high rates (up to 79%) of local tumor recurrence after surgery (11) (12) (13) . Despite the extremely high local recurrence rate, little has been investigated about treatment and clinical outcome of recurrent tumors. For better understanding of clinical course and establishment of better treatment strategy, we conducted a retrospective analysis of patients with recurrent MFS surgically treated at our institutes to primarily investigate the association between histological margin and re-recurrence rate. To our knowledge, this is the first report to characterize clinical features of the recurrent MFS.
Patients and methods

Patients
We identified a total of 141 patients with MFS that had been treated at Keio University Hospital (Keio: 41 patients) and National Cancer Center Hospital (NCCH: 100 patients) in Japan, between 1999 and 2008 on the database of these two hospitals. Of these cases, 36 patients (25.5%: Keio; 15 patients, NCCH; 21 patients) developed local recurrence after surgery. The details of clinical data were available in 30 cases (Keio; 15 patients, NCCH; 15 patients). The tumors were reviewed and histologically confirmed by certified pathologists based on the WHO classification of soft-tissue tumors (1, 2, 14, 15) . Demographic and clinical data, including age at surgery, gender, tumor location, details of surgery (wide, marginal, intraleisonal or amputation), a histological margin of surgery for the recurrent tumor, histological grade, radiotherapy status, period until re-recurrence after surgery, period until the re-recurrence after surgery, total number of surgeries in the follow-up period, time to amputation, amputation level, time to metastasis and the last follow-up, and oncological outcome, were retrieved from the database of Keio University Hospital and NCCH. All patients underwent MRI, including gadolinium-enhanced sequences for surgical planning, and the extent of tumor area was evaluated based on gadolinium-enhanced fat-suppressed T1-weighted images. Then, the surgical margin >2 cm from the distal portion of the tumor area was determined. If securing of the surgical margin >2 cm was possible, wide resection was performed; otherwise, patients underwent marginal resection, intralesional resection or amputation. Histological margins were evaluated after surgery in all patients. A histological negative margin was defined as the histological presence of normal tissues around the tumor, regardless of the distance from the surgical margin. Histological grades of primary, recurrent and re-recurrent tumors were determined based on the French Federation of Cancer Centers (FNCLCC grade) grading system. Decisions on whether to administer radiotherapy were made at multidisciplinary sarcoma group meetings. After the meetings, we provided objective data on the risks and benefits related to adjuvant therapies to the patients and conducted therapies only for patients who provided informed consent. For patients considered to have a higherthan-average risk of recurrence on the basis of clinical findings such as anatomical location and an inadequate margin expected on the basis of surgical planning, external beam radiation at doses ranging from 30 to 60 Gy was administered. On the other hand, systemic chemotherapy was only administered for the advanced patients with metastases at the discretion of the multidisciplinary sarcoma group and anthracyclinebased regimens were used in most patients. Patients' characteristics are summarized in Table 1 .
This study was approved by the ethical review boards of Keio University Hospital and NCCH.
Statistical analysis
Histological margin and tumor re-recurrence after surgery was used as the primary end point, and the re-recurrence rate was calculated from the date of surgery for recurrent tumors. The re-recurrence-free survival rate was estimated using the Kaplan-Meier method (16) . Relationships between the re-recurrence-free survival rate and other variables were investigated using the log-rank test for categorical variables. Differences at P < 0.05 were considered to be statistically significant (17) . Statistical computations were done using the JMP version 12.0.1 statistical software package (SAS Institute, Japan). The disease-free survival (DFS) and the amputation-free survival (AFS) rate were also estimated using the Kaplan-Meier method. The number of surgery, amputation and metastasis or death due to disease after surgery were used as the secondary end point, and were calculated from the date of surgery for recurrent tumors. Differences at P < 0.05 were considered to be statistically significant.
Results
The median follow-up period was 60 months (range, 2-210 months). The average age of the 30 patients at surgery for recurrent tumors was 70.2 years (range, 50-90 years), and there was a male predominance (20 males and 10 females). Twenty-one tumors were located in the extremities, including 10 in the upper limbs (8 in the forearm, 1 in the elbow and 1 in the upper arm), 11 in the lower limbs (1 in the ankle, 1 in the knee, 3 in the lower region of the leg and 6 in the thigh) and 9 in the trunk (4 in the limb girdle and 5 in the thoracoabdominal region). A total of six patients received neo-or adjuvant radiotherapy.
Histological margin and local re-recurrence
Surgery for recurrent MFS with a negative histological margin was achieved in only 12 patients (40.0%). The directions of positive margins, including horizontal and deep margins, were evaluable in 11 of 18 cases (Table 1) . Horizontal positive margins, deep positive margins and both were observed in 6 (54.5%), 10 (81.8%) and 5 cases (45.5%), respectively, demonstrating the achievement of negative deep margins in the great majority of recurrent cases. Re-recurrence after surgery was observed in 18 patients (60.0%) within a median period of 20.6 months (4-59 months). The 2-year and 5-year rerecurrence free survival (R-RFS) rates for the 30 MFS patients were 50.4% and 31.7%, respectively (Fig. 1A) . Re-recurrence was observed in 14 of the 18 patients with a positive histological margin (77.7%) and in 4 of the 12 patients (33.3%) with a negative histological margin.
Histological grades of primary, recurrent and re-recurrent tumors Table 1 ) progressed to a higher grade during the follow-up period (Fig. 1B) . 
Association between re-recurrence and clinical features
We also evaluated the association between MFS re-recurrence after surgery and clinical features, including a histological margin, tumor location, age at surgery for recurrent tumors, histological grade, positive margin direction and neo-or adjuvant radiotherapy. When the patients were stratified according to the histological margin, the estimated 2-year and 5-year R-RFS rates were 29.4% and 9.8% for those with positive histological margin, respectively, and 81.8% and 62.3% for those with negative histological margin, respectively (P = 0.006, Fig. 1C ). No association with MFS re-recurrence was found for other examined factors including age at surgery for recurrent tumors, tumor location, histological grade, positive margin direction and neo-or adjuvant radiotherapy ( Table 2 ).
The number of surgery in all cases and amputation for recurrent tumors in the extremities
The 30 patients with recurrent tumors underwent on mean 3 surgeries (range, 1-8 surgeries) including the first surgery for recurrent tumors in the follow-up period (Fig. 2) . Ten of the 21 patients with recurrent MFS in the extremities (47.6%) finally underwent amputation for tumor control in the follow-up period (median time to amputation; 46.0 months, range 2-154 months); the median time between surgery for the first recurrent tumor and amputation was 46 months (range, 25-127 months). The age of amputation surgery was ranged from 58 to 88 years (average, 71.6 years). The amputation level in these cases was 4 in hip disarticulation, 3 in above-elbow amputation, 1 in above-knee amputation, 1 in hemipelvectomy and 1 in below-knee amputation; in 9 out of 10 cases (90%), amputation was performed in very close to truncal site of extremities. The 2-year and 5-year AFS rates were 90.4% and 62.5%, respectively (Fig. 3) .
Distant metastasis, DFS and overall survival
We further investigated whether a positive histological margin was also correlated with the estimated DFS rate and overall survival (OAS). From the 30 patients included in this study, 4 patients (13.3%) had metastases in the follow-up period (median time to metastasis; 61.0 months, range 2-210 months): 3 in the lung and 1 in the lymph nodes (Table 1) . Of these four patients, two cases already had Grade 3 primary tumors (Cases 13 and 27; Table 1) , and a third progressed to a higher grade during the follow-up period (Case 30: Table 1 ). For these four patients, three had metastases after re-recurrence and two patients had metastases and rerecurrence at the same time (Case 13 and 24; Table 1 ). The 2-year and 5-year metastasis-free survival rates for the 30 MFS patients were 92.9% and 84.8%, respectively (Fig. 4A ). Among the 30 MFS patients, 21 showed no evidence of disease (NED), 4 were alive with disease (AWD) and 5 died of disease (DOD). Three of 5 patients with DOD died because of uncontrollable local situations including recurrence and infection after surgery despite the absence of metastases (Cases 1, 14 and 23; Table 1 ). These findings suggest that not only tumor metastasis but also uncontrollable local conditions may lead to DOD in recurrent MFS. The 2-year and 5-year DFS rates were 50.4% and 31.9%, respectively (Fig. 4B) . The 2-year and 5-year OAS rates were 96.6% and 83.6%, respectively (Fig. 4C) . A histological positive margin was also significantly related to the DFS rate (P = 0.006, Fig. 5A ). Although a histological positive margin was not significantly associated with OAS, the patients with a histological margin tended to have a poorer prognosis (Fig. 5B ).
Discussion
In this study, we especially focused on histological margin and rerecurrence rate after surgery. Our previous report indicated that surgery for primary tumors with a negative histological margin was achieved in 47 of the 64 patients (73.4%) and 5-year recurrence free-survival rate for primary cases was 74.8% (3). On the other hand, our present study demonstrated that surgery for recurrent tumors with a negative histological margin was only achieved in 12 patients (40.0%) and 5-year re-recurrence free-survival rate for recurrent cases was only 31.7%. These results indicated that it is more difficult to obtain a negative margin in recurrent MFS than in primary tumors. Waters et al. have reported that recurrent MFS has a particular propensity for infiltrative growth and demonstrate poorly defined margins on MRI unlike other types of soft-tissue sarcoma, it did not show an apparent pseudo-capsule in the images (4). Given this infiltrative tendency of recurrent MFS, the area of full tumor extension is either difficult to determine or is incorrectly estimated, which leads to insufficient resection due to inadequate margins, resulting in positive margins and re-recurrence after surgery. In fact, in the present study, a negative histological margin after surgery was only achieved in 12 patients (40.0%) and the estimated 5-year R-RFS rate was only 9.8% for those with positive histological margin and 62.3% for those with negative histological margin, respectively (P = 0.006, Fig. 1B ). Previous studies on primary MFS cases have reported that a positive histological margin was significantly associated with poor prognosis of primary MFS (3,13), suggesting that a histological margin is the most important prognostic indicator in MFS at all stages, including primary and recurrent tumors. Therefore, initial resection of a sufficient width based on accurately assessed surgical margins is the most important factor for local control in MFS at all stages. Our study indicated that the number of surgeries including the first surgery for recurrent tumors in the follow-up period was mean 3 times (range, 1-8 times), suggesting that patients with recurrent MFS tend to undergo multiple operations because of repetitively recurrent tumors. The reasons for multiple surgeries could be the following. First, resection of inadequate width leads to the dissemination of tumor cells via hemorrhage and edema beyond the original tumor site, which makes it more difficult to identify full MFS extent by MRI (18) . Second, normal tissue around the tumor is gradually lost over multiple operations, which significantly complicates surgery with wide margins, leading to inadequate resection and multiple subsequent recurrences. Third, the impact of radiotherapy and chemotherapy on relapse-free survival of MFS patients remains to be proven (5) (6) (7) (8) . Therefore, surgical resection is the only treatment of choice for recurrent tumors. Lastly, as proven in the present study, it is less common for MFS to metastasize to other organs and patients with MFS survive relatively long even with recurrent diseases. The multiple surgeries become physical and psychological burdens to patients with recurrent MFS. Furthermore, these difficulties in securing a surgical margin for recurrent tumors in the extremities ultimately result in amputation. In the present study, 10 of the 21 patients with MFS in the extremities had amputation and 9 of the 10 patients (90%) underwent amputations at the very close to truncal site of extremities to control recurrent tumors. The age of amputation in the most of these patients were elderly, ranging from 58 to 88 years (average, 71.6 years), which should affect the speed and extent of recovery. Previous studies have shown that patients with proximal amputation have significantly higher energy expenditure and increased demands on already stressed cardiovascular and pulmonary systems (19, 20) . In addition, it has been reported that elderly patients (>60 years old) with amputation had low functional activity (21) . These findings indicate that amputation, especially at the proximal level, may have serious adverse effects on the functional performance of MFS patients.
In conclusion, this study revealed that a histological margin after surgery was the only factor that was significantly associated with re-recurrence in recurrent MFS. The low rate of an achieved negative margin after surgery (only 40.0%) led to high local recurrence (5-year R-RFS: only 9.8%). These results suggested that surgical resection of a sufficient width based on accurately assessed surgical margins is the most important factor in recurrent MFS control. The re-recurrence in the extremities related to severe uncontrollable local conditions results in ultimate amputation and the vast of cases underwent amputations at the very close to truncal site of extremities to control recurrent tumors. Further studies are necessary to develop an appropriate treatment strategy for recurrent MFS.
